Dairy probiotics: Beyond the role of promoting gut and immune health

International Dairy Journal

Volumn 67, Issue , 2017, Pages 46-60

  Zoumpopoulou, Georgia ^a   Pot, Bruno ^b   Tsakalidou, Effie ^a   Papadimitriou, Konstantinos ^a  

^a AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^b VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN; FOOD PRODUCTS;

CARDIO-VASCULAR DISEASE; CURRENT RESEARCH STATUS; FERMENTED FOODS; FUTURE GENERATIONS; GENETICALLY MODIFIED; METABOLIC SYNDROMES; ORAL HEALTHS; THERAPEUTIC MOLECULES;

HEALTH;

EID: 85006717081     PISSN: 09586946     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.idairyj.2016.09.010     Document Type: Review

References (221)

1. Agarwal, P., Khatri, P., Billack, B., Low, W.K., Shao, J., Oral delivery of glucagon like peptide-1 by a recombinant Lactococcus lactis. Pharmaceutical Research 31 (2014), 3404–3414.
2. Aggarwal, J., Swami, G., Kumar, M., Probiotics and their effects on metabolic diseases: An update. Journal of Clinical and Diagnostic Research 7 (2013), 173–177.
3. Ahola, A.J., Yli-Knuuttila, H., Suomalainen, T., Poussa, T., Ahlstrom, A., Meurman, J.H., et al. Short-term consumption of probiotic-containing cheese and its effect on dental caries risk factors. Archives of Oral Biology 47 (2002), 799–804.
4. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., et al. Clinical and metabolic response to probiotic administration in patients with major depressive disorder: A randomized, double-blind, placebo-controlled trial. Nutrition 32 (2016), 315–320.
5. Alard, J., Lehrter, V., Rhimi, M., Mangin, I., Peucelle, V., Abraham, A.L., et al. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environmental Microbiology 18 (2016), 1484–1497.
6. An, H.M., Park, S.Y., Lee, D.K., Kim, J.R., Cha, M.K., Lee, S.W., et al. Antiobesity and lipid-lowering effects of Bifidobacterium spp. in high fat diet-induced obese rats. Lipids in Health and Disease, 10, 2011 116–116.
7. Angelakis, E., Merhej, V., Raoult, D., Related actions of probiotics and antibiotics on gut microbiota and weight modification. Lancet Infectious Diseases 13 (2013), 889–899.
8. Aronsson, L., Huang, Y., Parini, P., Korach-Andre, M., Hakansson, J., Gustafsson, J.A., et al. Decreased fat storage by Lactobacillus paracasei is associated with increased levels of angiopoietin-like 4 protein (ANGPTL4). PLoS One, 5, 2010, e13087.
9. Arora, T., Singh, S., Sharma, R.K., Probiotics: Interaction with gut microbiome and antiobesity potential. Nutrition 29 (2013), 591–596.
10. Aso, Y., Akaza, H., Kotake, T., Tsukamoto, T., Imai, K., Naito, S., Preventive effect of a Lactobacillus casei preparation on the recurrence of superficial bladder cancer in a double blind trial. The BLP Study Group. European Urology 27 (1995), 104–109.
11. de Azevedo, M., Karczewski, J., Lefevre, F., Azevedo, V., Miyoshi, A., Wells, J.M., et al. In vitro and in vivo characterization of DNA delivery using recombinant Lactococcus lactis expressing a mutated form of L. monocytogenes Internalin A. BMC Microbiology, 12, 2012 article no. 299.
12. Bahey-El-Din, M., Casey, P.G., Griffin, B.T., Gahan, C.G., Efficacy of a Lactococcus lactis DeltapyrG vaccine delivery platform expressing chromosomally integrated hly from Listeria monocytogenes. Bioengineered Bugs 1 (2010), 66–74.
13. Belizario, J.E., Napolitano, M., Human microbiomes and their roles in dysbiosis, common diseases and novel therapeutic approaches. Frontiers in Microbiology, 6, 2015 article no. 1050.
14. Benbouziane, B., Ribelles, P., Aubry, C., Martin, R., Kharrat, P., Riazi, A., et al. Development of a stress-inducible controlled expression (SICE) system in Lactococcus lactis for the production and delivery of therapeutic molecules at mucosal surfaces. Journal of Biotechnology 168 (2013), 120–129.
15. Benton, D., Williams, C., Brown, A., Impact of consuming a milk drink containing a probiotic on mood and cognition. European Journal of Clinical Nutrition 61 (2006), 355–361.
16. Bermudez-Humaran, L.G., Kharrat, P., Chatel, J.M., Langella, P., Lactococci and lactobacilli as mucosal delivery vectors for therapeutic proteins and DNA vaccines. Microbial Cell Factories, 10(Suppl. 1), 2011 article no.S4.
17. Bermudez-Humaran, L.G., Langella, P., Miyoshi, A., Gruss, A., Guerra, R.T., Montes de Oca-Luna, R., et al. Production of human papillomavirus type 16 E7 protein in Lactococcus lactis. Applied and Environmental Microbiology 68 (2002), 917–922.
18. Bermudez-Humaran, L.G., Nouaille, S., Zilberfarb, V., Corthier, G., Gruss, A., Langella, P., et al. Effects of intranasal administration of a leptin-secreting Lactococcus lactis recombinant on food intake, body weight, and immune response of mice. Applied and Environmental Microbiology 73 (2007), 5300–5307.
19. Bindels, L.B., Porporato, P., Dewulf, E.M., Verrax, J., Neyrinck, A.M., Martin, J.C., et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. British Journal of Cancer 107 (2012), 1337–1344.
20. Boltin, D., Probiotics in Helicobacter pylori-induced peptic ulcer disease. Best Practice and Research. Clinical Gastroenterology 30 (2016), 99–109.
21. Bonifait, L., Chandad, F., Grenier, D., Probiotics for oral health: Myth or reality?. Journal Canadian Dental Association 75 (2009), 585–590.
22. Bordoni, A., Amaretti, A., Leonardi, A., Boschetti, E., Danesi, F., Matteuzzi, D., et al. Cholesterol-lowering probiotics: In vitro selection and in vivo testing of bifidobacteria. Applied Microbiology and Biotechnology 97 (2013), 8273–8281.
23. Bosch, M., Nart, J., Audivert, S., Bonachera, M.A., Alemany, A.S., Fuentes, M.C., et al. Isolation and characterization of probiotic strains for improving oral health. Archives of Oral Biology 57 (2012), 539–549.
24. Boulange, C.L., Neves, A.L., Chilloux, J., Nicholson, J.K., Dumas, M.E., Impact of the gut microbiota on inflammation, obesity, and metabolic disease. Genome Medicine, 8, 2016 article no. 42.
25. Bravo, J.A., Forsythe, P., Chew, M.V., Escaravage, E., Savignac, H.M., Dinan, T.G., et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proceedings of the National Academy of Sciences 108 (2011), 16050–16055.
26. Byrne, C.S., Chambers, E.S., Morrison, D.J., Frost, G., The role of short chain fatty acids in appetite regulation and energy homeostasis. International Journal of Obesity 39 (2015), 1331–1338.
27. Caballero-Franco, C., Keller, K., De Simone, C., Chadee, K., The VSL#3 probiotic formula induces mucin gene expression and secretion in colonic epithelial cells. American Journal of Physiology. Gastrointestinal and Liver Physiology 292 (2007), G315–G322.
28. Caglar, E., Kuscu, O.O., Selvi Kuvvetli, S., Kavaloglu Cildir, S., Sandalli, N., Twetman, S., Short-term effect of ice-cream containing Bifidobacterium lactis Bb-12 on the number of salivary mutans streptococci and lactobacilli. Acta Odontologica Scandinavica 66 (2008), 154–158.
29. Caglar, E., Sandalli, N., Twetman, S., Kavaloglu, S., Ergeneli, S., Selvi, S., Effect of yogurt with Bifidobacterium DN-173 010 on salivary mutans streptococci and lactobacilli in young adults. Acta odontologica Scandinavica 63 (2005), 317–320.
30. Cani, P.D., Possemiers, S., Van de Wiele, T., Guiot, Y., Everard, A., Rottier, O., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2 driven improvement of gut permeability. Gut 58 (2009), 1091–1103.
31. Cano-Garrido, O., Seras-Franzoso, J., Garcia-Fruitós, E., Lactic acid bacteria: Reviewing the potential of a promising delivery live vector for biomedical purposes. Microbial Cell Factories, 14, 2015 article no. 137.
32. Chatel, J.M., Pothelune, L., Ah-Leung, S., Corthier, G., Wal, J.M., Langella, P., In vivo transfer of plasmid from food-grade transiting lactococci to murine epithelial cells. Gene Therapy 15 (2008), 1184–1190.
33. Chen, J., Wang, R., Li, X.F., Wang, R.L., Bifidobacterium adolescentis supplementation ameliorates visceral fat accumulation and insulin sensitivity in an experimental model of the metabolic syndrome. British Journal of Nutrition 107 (2012), 1429–1434.
34. Chinnappa, A., Konde, H., Konde, S., Raj, S., Beena, J.P., Probiotics for future caries control: A short-term clinical study. Indian Journal of Dental Research 24 (2013), 547–549.
35. Cildir, S.K., Germec, D., Sandalli, N., Ozdemir, F.I., Arun, T., Twetman, S., et al. Reduction of salivary mutans streptococci in orthodontic patients during daily consumption of yoghurt containing probiotic bacteria. European Journal of Orthodontics 31 (2009), 407–411.
36. Collins, J., Borojevic, R., Verdu, E.F., Huizinga, J.D., Ratcliffe, E.M., Intestinal microbiota influence the early postnatal development of the enteric nervous system. Neurogastroenterology and Motility 26 (2014), 98–107.
37. Collins, S.M., Kassam, Z., Bercik, P., The adoptive transfer of behavioral phenotype via the intestinal microbiota: Experimental evidence and clinical implications. Current Opinion in Microbiology 16 (2013), 240–245.
38. Colloca, M.E., Ahumada, M.C., Lopez, M.E., Nader-Macias, M.E., Surface properties of lactobacilli isolated from healthy subjects. Oral Diseases 6 (2000), 227–233.
39. Comelli, E.M., Guggenheim, B., Stingele, F., Neeser, J.R., Selection of dairy bacterial strains as probiotics for oral health. European Journal of Oral Sciences 110 (2002), 218–224.
40. Commane, D., Hughes, R., Shortt, C., Rowland, I., The potential mechanisms 905 involved in the anti-carcinogenic action of probiotics. Mutation Research 591 (2005), 276–289.
41. Cousin, F.J., Mater, D.D.G., Foligné, B., Jan, G., Dairy propionibacteria as human probiotics: A review of recent evidence. Dairy Science and Technology 91 (2011), 1–26.
42. Cowan, C.S., Callaghan, B.L., Richardson, R., The effects of a probiotic formulation (Lactobacillus rhamnosus and L. helveticus) on developmental trajectories of emotional learning in stressed infant rats. Translational Psychiatry, 6, 2016, e823.
43. Daniel, C., Repa, A., Mercenier, A., Wiedermann, U., Wells, J., The European LABDEL project and its relevance to the prevention and treatment of allergies. Allergy 62 (2007), 1237–1242.
44. Daniel, C., Roussel, Y., Kleerebezem, M., Pot, B., Recombinant lactic acid bacteria as mucosal biotherapeutic agents. Trends in Biotechnology 29 (2011), 499–508.
45. Dao, M.C., Everard, A., Aron-Wisnewsky, J., Sokolovska, N., Prifti, E., Verger, E.O., et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: Relationship with gut microbiome richness and ecology. Gut 65 (2016), 426–436.
46. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J.F., Dinan, T.G., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (2010), 1179–1188.
47. Dinan, T.G., Stanton, C., Cryan, J.F., Psychobiotics: A novel class of psychotropic. Biological Psychiatry 74 (2013), 720–726.
48. Dinan, T.G., Stilling, R.M., Stanton, C., Cryan, J.F., Collective unconscious: How gut microbes shape human behavior. Journal of Psychiatric Research 63 (2015), 1–9.
49. Dong, J.Y., Szeto, I.M., Makinen, K., Gao, Q., Wang, J., Qin, L.Q., et al. Effect of probiotic fermented milk on blood pressure: A meta-analysis of randomised controlled trials. British Journal of Nutrition 110 (2013), 1188–1194.
50. Drissi, F., Merhej, V., Angelakis, E., El Kaoutari, A., Carriere, F., Henrissat, B., et al. Comparative genomics analysis of Lactobacillus species associated with weight gain or weight protection. Nutrition and Diabetes, 4, 2014, e109.
51. Drissi, F., Raoult, D., Merhej, V., Metabolic role of lactobacilli in weight modification in humans and animals. Microbial Pathogenesis, 2016 in press.
52. Eckburg, P.B., Bik, E.M., Bernstein, C.N., Purdom, E., Dethlefsen, L., Sargent, M., et al. Diversity of the human intestinal microbial flora. Science 308 (2005), 1635–1638.
53. Ejtahed, H.S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., Mofid, V., et al. Effect of probiotic yogurt containing Lactobacillus acidophilus and Bifidobacterium lactis on lipid profile in individuals with type 2 diabetes mellitus. Journal of Dairy Science 94 (2011), 3288–3294.
54. Ejtahed, H.S., Mohtadi-Nia, J., Homayouni-Rad, A., Niafar, M., Asghari-Jafarabadi, M., Mofid, V., Probiotic yogurt improves antioxidant status in type 2 diabetic patients. Nutrition 28 (2012), 539–543.
55. Everard, A., Belzer, C., Geurts, L., Ouwerkerk, J.P., Druart, C., Bindels, L.B., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proceedings of the National Academy of Sciences of the United States of America 110 (2013), 9066–9071.
56. Evrensel, A., Ceylan, M.E., The gut-brain axis: The missing link in depression. Clinical Psychopharmacology and Neuroscience 13 (2015), 239–244.
57. Fahey, J.W., Stephenson, K.K., Wallace, A.J., Dietary amelioration of Helicobacter infection. Nutrition Research 35 (2015), 461–473.
58. FAO/WHO, Joint FAO/WHO working group on drafting guidelines for the evaluation of probiotics in food. Guidelines for the evaluation of probiotics in food: report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food, 2002, FAO/WHO, London, ON, Canada.
59. Filoche, S., Wong, L., Sissons, C.H., Oral biofilms: Emerging concepts in microbial ecology. Journal of Dental Research 89 (2010), 8–18.
60. Forsythe, P., Bienenstock, J., Kunze, W.A., Vagal pathways for microbiome-brain-gut axis communication. Advances in Experimental Medicine and Biology 817 (2014), 115–133.
61. Fujimori, M., Genetically engineered Bifidobacterium as a drug delivery system for systemic therapy of metastatic breast cancer patients. Breast Cancer 13 (2006), 27–31.
62. Gao, G., Qiao, J.J., Yang, C.H., Jiang, D.Z., Li, R.Q., Su, J.J., et al. Functional expression of mouse insulin-like growth factor-I with food-grade vector in Lactococcus lactis NZ9000. Letters in Applied Microbiology 54 (2012), 404–409.
63. Gianotti, L., Morelli, L., Galbiati, F., Rocchetti, S., Coppola, S., Beneduce, A., et al. A randomized double-blind trial on perioperative administration of probiotics in colorectal cancer patients. World Journal of Gastroenterology 16 (2010), 167–175.
64. Glavina, D., Gorseta, K., Skrinjaric, I., Vranic, D.N., Mehulic, K., Kozul, K., Effect of LGG yoghurt on Streptococcus mutans and Lactobacillus spp. salivary counts in children. Collegium Antropologicum 36 (2012), 129–132.
65. Gratz, S., Wu, Q.K., El-Nezami, H., Juvonen, R.O., Mykkanen, H., Turner, P.C., Lactobacillus rhamnosus strain GG reduces aflatoxin B1 transport, metabolism, and toxicity in Caco-2 Cells. Applied and Environmental Microbiology 73 (2007), 3958–3964.
66. Gruner, D., Paris, S., Schwendicke, F., Probiotics for managing caries and periodontitis: Systematic review and meta-analysis. Journal of Dentistry 48 (2016), 16–25.
67. Guarino, A., Guandalini, S., Lo Vecchio, A., Probiotics for prevention and treatment of diarrhea. Journal of Clinical Gastroenterology 49 (2015), S37–S45.
68. Guimaraes, V.D., Innocentin, S., Lefevre, F., Azevedo, V., Wal, J.M., Langella, P., et al. Use of native lactococci as vehicles for delivery of DNA into mammalian epithelial cells. Applied and Environmental Microbiology 72 (2006), 7091–7097.
69. Hatakka, K., Ahola, A.J., Yli-Knuuttila, H., Richardson, M., Poussa, T., Meurman, J.H., et al. Probiotics reduce the prevalence of oral Candida in the elderly-a randomized controlled trial. Journal of Dental Research 86 (2007), 125–130.
70. Hatakka, K., Holma, R., El-Nezami, H., Suomalainen, T., Kuisma, M., Saxelin, M., et al. The influence of Lactobacillus rhamnosus LC705 together with Propionibacterium freudenreichii ssp. shermanii JS on potentially carcinogenic bacterial activity in human colon. International Journal of Food Microbiology 128 (2008), 406–410.
71. Hatakka, K., Savilahti, E., Pönkä, A., Meurman, J.H., Poussa, T., Näse, L., et al. Effect of long term consumption of probiotic milk on infections in children attending day care centres: Double blind, randomised trial. British Medical Journal, 322, 2001 1327–1327.
72. Haukioja, A., Probiotics and oral health. European Journal of Dentistry 4 (2010), 348–355.
73. Haukioja, A., Yli-Knuuttila, H., Loimaranta, V., Kari, K., Ouwehand, A.C., Meurman, J.H., et al. Oral adhesion and survival of probiotic and other lactobacilli and bifidobacteria in vitro. Oral Microbiology and Immunology 21 (2006), 326–332.
74. Hill, C., Guarner, F., Reid, G., Gibson, G.R., Merenstein, D.J., Pot, B., et al. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature Reviews. Gastroenterology and Hepatology 11 (2014), 506–514.
75. Hisbergues, M., Magi, M., Rigaux, P., Steuve, J., Garcia, L., Goudercourt, D., et al. In vivo and in vitro immunomodulation of Der p 1 allergen-specific response by Lactobacillus plantarum bacteria. Clinical and Experimental Allergy 37 (2007), 1286–1295.
76. Hongying, F., Xianbo, W., Fang, Y., Yang, B., Beiguo, L., Oral immunization with recombinant Lactobacillus acidophilus expressing the adhesin Hp0410 of Helicobacter pylori induces mucosal and systemic immune responses. Clinical and Vaccine Immunology 21 (2014), 126–132.
77. Hugentobler, F., Di Roberto, R.B., Gillard, J., Cousineau, B., Oral immunization using live Lactococcus lactis co-expressing LACK and IL-12 protects BALB/c mice against Leishmania major infection. Vaccine 30 (2012), 5726–5732.
78. Hugentobler, F., Yam, K.K., Gillard, J., Mahbuba, R., Olivier, M., Cousineau, B., Immunization against Leishmania major infection using LACK-and IL-12-expressing Lactococcus lactis induces delay in footpad swelling. PLoS One, 7, 2012, e30945.
79. Hulston, C.J., Churnside, A.A., Venables, M.C., Probiotic supplementation prevents fat, overfeeding-induced, insulin resistance in humans. British Journal of Nutrition 113 (2015), 596–602.
80. Ishikawa, H., Akedo, I., Otani, T., Suzuki, T., Nakamura, T., Takeyama, I., et al. Randomized trial of dietary fiber and Lactobacillus casei administration for prevention of colorectal tumors. International Journal of Cancer 116 (2005), 762–767.
81. Ivey, K.L., Hodgson, J.M., Kerr, D.A., Thompson, P.L., Stojceski, B., Prince, R.L., The effect of yoghurt and its probiotics on blood pressure and serum lipid profile; a randomised controlled trial. Nutrition, Metabolism and Cardiovascular Diseases 25 (2015), 46–51.
82. Iwaki, M., Okahashi, N., Takahashi, I., Kanamoto, T., Sugita-Konishi, Y., Aibara, K., et al. Oral immunization with recombinant Streptococcus lactis carrying the Streptococcus mutans surface protein antigen gene. Infection and Immunity 58 (1990), 2929–2934.
83. Jan, G., Belzacq, A.S., Haouzi, D., Rouault, A., Metivier, D., Kroemer, G., et al. Propionibacteria induce apoptosis of colorectal carcinoma cells via short-chain fatty acids acting on mitochondria. Cell Death and Differentiation 9 (2002), 179–188.
84. Jing, H., Yong, L., Haiyan, L., Yanjun, M., Yun, X., Yu, Z., et al. Oral administration of Lactococcus lactis delivered heat shock protein 65 attenuates atherosclerosis in low-density lipoprotein receptor-deficient mice. Vaccine 29 (2011), 4102–4109.
85. Juneja, A., Kakade, A., Evaluating the effect of probiotic containing milk on salivary mutans streptococci levels. Journal of Clinical Pediatric Dentistry 37 (2012), 9–14.
86. Kadooka, Y., Sato, M., Imaizumi, K., Ogawa, A., Ikuyama, K., Akai, Y., et al. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. European Journal of Clinical Nutrition 64 (2010), 636–643.
87. Kadooka, Y., Sato, M., Ogawa, A., Miyoshi, M., Uenishi, H., Ogawa, H., et al. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. British Journal of Nutrition 110 (2013), 1696–1703.
88. Kajikawa, A., Zhang, L., Long, J., Nordone, S., Stoeker, L., LaVoy, A., et al. Construction and immunological evaluation of dual cell surface display of HIV-1 gag and Salmonella enterica serovar Typhimurium FliC in Lactobacillus acidophilus for vaccine delivery. Clinical and Vaccine Immunology 19 (2012), 1374–1381.
89. Kandasamy, M., Bay, B.H., Lee, Y.K., Mahendran, R., Lactobacilli secreting a tumor antigen and IL15 activates neutrophils and dendritic cells and generates cytotoxic T lymphocytes against cancer cells. Cellular Immunology 271 (2011), 89–96.
90. Karuppaiah, R.M., Shankar, S., Raj, S.K., Ramesh, K., Prakash, R., Kruthika, M., Evaluation of the efficacy of probiotics in plaque reduction and gingival health maintenance among school children-a randomized control trial. Journal of International Oral Health 5 (2013), 33–37.
91. Kasinska, M.A., Drzewoski, J., Effectiveness of probiotics in type 2 diabetes: A meta-analysis. Polskie Archiwum Medycyny Wewnetrznej 125 (2015), 803–813.
92. Kelly, J.R., Clarke, G., Cryan, J.F., Dinan, T.G., Brain-gut-microbiota axis: Challenges for translation in psychiatry. Annals of Epidemiology 26 (2016), 366–372.
93. Kennedy, A., Martinez, K., Schmidt, S., Mandrup, S., LaPoint, K., McIntosh, M., Antiobesity mechanisms of action of conjugated linoleic acid. Journal of Nutritional Biochemistry 21 (2010), 171–179.
94. Khalesi, S., Sun, J., Buys, N., Jayasinghe, R., Effect of probiotics on blood pressure: A systematic review and meta-analysis of randomized, controlled trials. Hypertension 64 (2014), 897–903.
95. Kleerebezem, M., Vaughan, E.E., Probiotic and gut lactobacilli and bifidobacteria: Molecular approaches to study diversity and activity. Annual Review of Microbiology 63 (2009), 269–290.
96. Kobyliak, N., Virchenko, O., Falalyeyeva, T., Pathophysiological role of host microbiota in the development of obesity. Nutrition Journal, 15, 2016 article no. 43.
97. Koll-Klais, P., Mandar, R., Leibur, E., Marcotte, H., Hammarstrom, L., Mikelsaar, M., Oral lactobacilli in chronic periodontitis and periodontal health: Species composition and antimicrobial activity. Oral Microbiology and Immunology 20 (2005), 354–361.
98. Krajmalnik-Brown, R., Ilhan, Z.E., Kang, D.W., DiBaise, J.K., Effects of gut microbes on nutrient absorption and energy regulation. Nutrition in Clinical Practice 27 (2012), 201–214.
99. Kumar, M., Nagpal, R., Kumar, R., Hemalatha, R., Verma, V., Kumar, A., et al. Lowering probiotics as potential biotherapeutics for metabolic diseases. Experimental Diabetes Research 2012 (2012), 902–917.
100. Kumar, D., Singh, G., Singh, M., Sharma, D., Singh Rathore, M., Diet and functional foods in treatment and maintenance therapy of colon disorders. Journal of Applied Pharmaceutical Science 2 (2012), 177–187.
101. Kuramitsu, H.K., He, X., Lux, R., Anderson, M.H., Shi, W., Interspecies interactions within oral microbial communities. Microbiology and Molecular Biology Reviews 71 (2007), 653–670.
102. de La Serre, C.B., Ellis, C.L., Lee, J., Hartman, A.L., Rutledge, J.C., Raybould, H.E., Propensity to high-fat diet-induced obesity in rats is associated with changes in the gut microbiota and gut inflammation. American Journal of Physiology. Gastrointestinal and Liver Physiology 299 (2010), G440–G448.
103. Laleman, I., Detailleur, V., Slot, D.E., Slomka, V., Quirynen, M., Teughels, W., Probiotics reduce mutans streptococci counts in humans: A systematic review and meta-analysis. Clinical Oral Investigations 18 (2014), 1539–1552.
104. Lan, A., Bruneau, A., Bensaada, M., Philippe, C., Bellaud, P., Rabot, S., et al. Increased induction of apoptosis by Propionibacterium freudenreichii TL133 in colonic mucosal crypts of human microbiota-associated rats treated with 1,2-dimethylhydrazine. British Journal of Nutrition 100 (2008), 1251–1259.
105. Lan, A., Lagadic-Gossmann, D., Lemaire, C., Brenner, C., Jan, G., Acidic extracellular pH shifts colorectal cancer cell death from apoptosis to necrosis upon exposure to propionate and acetate, major end-products of the human probiotic propionibacteria. Apoptosis 12 (2007), 573–591.
106. Le Barz, M., Anhê, F.F., Varin, T.V., Desjardins, Y., Levy, E., Roy, D., et al. Probiotics as complementary treatment for metabolic disorders. Diabetes and Metabolism Journal 39 (2015), 291–303.
107. LeBlanc, J.G., Aubry, C., Cortes-Perez, N.G., de Moreno de LeBlanc, A., Vergnolle, N., Langella, P., et al. Mucosal targeting of therapeutic molecules using genetically modified lactic acid bacteria: An update. FEMS Microbiology Letters 344 (2013), 1–9.
108. LeBlanc, J.G., Milani, C., de Giori, G.S., Sesma, F., van Sinderen, D., Ventura, M., Bacteria as vitamin suppliers to their host: A gut microbiota perspective. Current Opinion in Biotechnology 24 (2013), 160–168.
109. Lee, P., Biocontainment strategies for live lactic acid bacteria vaccine vectors. Bioengineered Bugs 1 (2010), 75–77.
110. Lee, J.Y., Chu, S.H., Jeon, J.Y., Lee, M.K., Park, J.H., Lee, D.C., et al. Effects of 12 weeks of probiotic supplementation on quality of life in colorectal cancer survivors: A double-blind, randomized, placebo-controlled trial. Digestive and Liver Disease 46 (2014), 1126–1132.
111. Lee, K., Paek, K., Lee, H.Y., Park, J.H., Lee, Y., Antiobesity effect of trans-10,cis-12conjugated linoleic acid-producing Lactobacillus plantarum PL62 on diet-induced obese mice. Journal of Applied Microbiology 103 (2007), 1140–1146.
112. Lee, H.Y., Park, J.-H., Seok, S.-H., Baek, M.-W., Kim, D.-J., Lee, K.-E., et al. Human originated bacteria, Lactobacillus rhamnosus PL60, produce conjugated linoleic acid and show anti-obesity effects in diet-induced obese mice. Biochimica et Biophysica Acta (BBA) Molecular and Cell Biology of Lipids 1761 (2006), 736–744.
113. Lexner, M.O., Blomqvist, S., Dahlen, G., Twetman, S., Microbiological profiles in saliva and supragingival plaque from caries-active adolescents before and after a short-term daily intake of milk supplemented with probiotic bacteria-a pilot study. Oral Health and Preventive Dentistry 8 (2010), 383–388.
114. Li, X., Fu, G.F., Fan, Y.R., Liu, W.H., Liu, X.J., Wang, J.J., et al. Bifidobacterium adolescentis as a delivery system of endostatin for cancer gene therapy: Selective inhibitor of angiogenesis and hypoxic tumor growth. Cancer Gene Therapy 10 (2003), 105–111.
115. Li, Y.G., Tian, F.L., Gao, F.S., Tang, X.S., Xia, C., Immune responses generated by Lactobacillus as a carrier in DNA immunization against foot-and-mouth disease virus. Vaccine 25 (2007), 902–911.
116. Lima, L.M., Motisuki, C., Spolidorio, D.M., Santos-Pinto, L., In vitro evaluation of probiotics microorganisms adhesion to an artificial caries model. European Journal of Clinical Nutrition 59 (2005), 884–886.
117. Limaye, S.A., Haddad, R.I., Cilli, F., Sonis, S.T., Colevas, A.D., Brennan, M.T., et al. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer 119 (2013), 4268–4276.
118. Liu, Z.H., Huang, M.J., Zhang, X.W., Wang, L., Huang, N.Q., Peng, H., et al. The effects of perioperative probiotic treatment on serum zonulin concentration and subsequent postoperative infectious complications after colorectal cancer surgery: A double-center and double-blind randomized clinical trial. American Journal of Clinical Nutrition 97 (2013), 117–126.
119. Liu, Z., Qin, H., Yang, Z., Xia, Y., Liu, W., Yang, J., et al. Randomised clinical trial: The effects 1134 of perioperative probiotic treatment on barrier function and post-operative infectious complications in colorectal cancer surgery -a double-blind study. Alimentary Pharmacology and Therapeutics 33 (2011), 50–63.
120. Ma, Y., Liu, J., Hou, J., Dong, Y., Lu, Y., Jin, L., et al. Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice. PLoS One, 9, 2014, e105701.
121. MacFabe, D.F., Short-chain fatty acid fermentation products of the gut microbiome: Implications in autism spectrum disorders. Microbial Ecology in Health and Disease, 23, 2012 article no. 19260.
122. Maes, M., Kubera, M., Leunis, J.C., The gut-brain barrier in major depression: Intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinology Letters 29 (2008), 117–124.
123. Maes, M., Mihaylova, I., Leunis, J.C., Increased serum IgA and IgM against LPS of enterobacteria in chronic fatigue syndrome (CFS): Indication for the involvement of gram negative enterobacteria in the etiology of CFS and for the presence of an increased gut-intestinal permeability. Journal of Affective Disorders 99 (2007), 237–240.
124. Manocha, M., Khan, W.I., Serotonin and GI disorders: An update on clinical and experimental studies. Clinical and Translational Gastroenterology, 3, 2012, e13.
125. Marchesi, J.R., Adams, D.H., Fava, F., Hermes, G.D.A., Hirschfield, G.M., Hold, G., et al. The gut microbiota and host health: A new clinical frontier. Gut 65 (2016), 330–339.
126. Marelli, B., Perez, A.R., Banchio, C., de Mendoza, D., Magni, C., Oral immunization with live Lactococcus lactis expressing rotavirus VP8 subunit induces specific immune response in mice. Journal of Virological Methods 175 (2011), 28–37.
127. Martin-Cabezas, R., Davideau, J.L., Tenenbaum, H., Huck, O., Clinical efficacy of probiotics as an adjunctive therapy to non-surgical periodontal treatment of chronic periodontitis: A systematic review and meta-analysis. Journal of Clinical Periodontology 43 (2016), 520–530.
128. Matsui, R., Cvitkovitch, D., Acid tolerance mechanisms utilized by Streptococcus mutans. Future Microbiology 5 (2010), 403–417.
129. Mawe, G.M., Hoffman, J.M., Serotonin signaling in the gastrointestinal tract: Functions, dysfunctions, and therapeutic targets. Nature reviews. Gastroenterology and Hepatology 10 (2013), 473–486.
130. McBain, A., Madhwani, T., Eatough, J., Ledder, R., An introduction to probiotics for dental health. Food Science and Technology Bulletin Functional Foods 6 (2009), 5–29.
131. Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., et al. Assessment of psychotropic-like properties of a probiotic formulation (Lactobacillus helveticus R0052 and Bifidobacterium longum R0175) in rats and human subjects. British Journal of Nutrition 105 (2011), 755–764.
132. Meurman, J.H., Probiotics: Do they have a role in oral medicine and dentistry?. European Journal of Oral Sciences 113 (2005), 188–196.
133. Mierau, I., Kleerebezem, M., 10 years of the nisin-controlled gene expression system (NICE) in Lactococcus lactis. Applied Microbiology and Biotechnology 68 (2005), 705–717.
134. Million, M., Angelakis, E., Paul, M., Armougom, F., Leibovici, L., Raoult, D., Comparative meta-analysis of the effect of Lactobacillus species on weight gain in humans and animals. Microbial Pathogenesis 53 (2012), 100–108.
135. Minic, R., Gavrovic-Jankulovic, M., Petrusic, V., Zivkovic, I., Eijsink, V.G., Dimitrijevic, L., et al. Effects of orally applied Fes p1-displaying L. plantarum WCFS1 on Fes p1 induced allergy in mice. Journal of Biotechnology 199 (2015), 23–28.
136. Miquel, S., Martin, R., Rossi, O., Bermudez-Humaran, L.G., Chatel, J.M., Sokol, H., et al. Faecalibacterium prausnitzii and human intestinal health. Current Opinion in Microbiology 16 (2013), 255–261.
137. Miyoshi, A., Jamet, E., Commissaire, J., Renault, P., Langella, P., Azevedo, V., A inducible expression system for Lactococcus lactis. FEMS Microbiology Letters 239 (2004), 205–212.
138. Moos, W.H., Faller, D.V., Harpp, D.N., Kanara, I., Pernokas, J., Powers, W.R., et al. Microbiota and neurological disorders: A gut feeling. BioResearch Open Access 5 (2016), 137–145.
139. de Moreno de LeBlanc, A., LeBlanc, J.G., Perdigon, G., Miyoshi, A., Langella, P., Azevedo, V., et al. Oral administration of a catalase-producing Lactococcus lactis can prevent a chemically induced colon cancer in mice. Journal of Medical Microbiology 57 (2008), 100–105.
140. Naito, S., Koga, H., Yamaguchi, A., Fujimoto, N., Hasui, Y., Kuramoto, H., et al. Prevention of recurrence with epirubicin and Lactobacillus casei after transurethral resection of bladder cancer. Journal of Urology 179 (2008), 485–490.
141. Nase, L., Hatakka, K., Savilahti, E., Saxelin, M., Ponka, A., Poussa, T., et al. Effect of term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Research 35 (2001), 412–420.
142. Nerstedt, A., Nilsson, E.C., Ohlson, K., Hakansson, J., Thomas Svensson, L., Lowenadler, B., et al. Administration of Lactobacillus evokes coordinated changes in the intestinal expression profile of genes regulating energy homeostasis and immune phenotype in mice. British Journal of Nutrition 97 (2007), 1117–1127.
143. Nieuwdorp, M., Gilijamse, P.W., Pai, N., Kaplan, L.M., Role of the microbiome in energy regulation and metabolism. Gastroenterology 146 (2014), 1525–1533.
144. Nikawa, H., Makihira, S., Fukushima, H., Nishimura, H., Ozaki, Y., Ishida, K., et al. Lactobacillus reuteri in bovine milk fermented decreases the oral carriage of mutans streptococci. International Journal of Food Microbiology 95 (2004), 219–223.
145. Ogawa, S., Fujii, T., Koga, N., Hori, H., Teraishi, T., Hattori, K., et al. Plasma l-tryptophan concentration in major depressive disorder: New data and meta-analysis. Journal of Clinical Psychiatry 75 (2014), e906–e915.
146. O'Hara, A.M., Shanahan, F., The gut flora as a forgotten organ. EMBO Reports 7 (2006), 688–693.
147. Ohashi, Y., Nakai, S., Tsukamoto, T., Masumori, N., Akaza, H., Miyanaga, N., et al. Habitual intake of lactic acid bacteria and risk reduction of bladder cancer. Urologia Internationalis 68 (2002), 273–280.
148. Ohkouchi, K., Kawamoto, S., Tatsugawa, K., Yoshikawa, N., Takaoka, Y., Miyauchi, S., et al. Prophylactic effect of Lactobacillus oral vaccine expressing a Japanese cedar pollen allergen. Journal of Bioscience and Bioengineering 113 (2012), 536–541.
149. O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behavioural Brain Research 277 (2015), 32–48.
150. O'Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 128 (2005), 541–551.
151. Omar, J.M., Chan, Y.-M., Jones, M.L., Prakash, S., Jones, P.J.H., Lactobacillus fermentum and Lactobacillus amylovorus as probiotics alter body adiposity and gut microflora in healthy persons. Journal of Functional Foods 5 (2013), 116–123.
152. Ouwehand, A.C., Lagstrom, H., Suomalainen, T., Salminen, S., Effect of probiotics on constipation, fecal azoreductase activity and fecal mucin content in the elderly. Annals of Nutrition and Metabolism 46 (2002), 159–162.
153. Ouwehand, A.C., Salminen, S., Isolauri, E., Probiotics: An overview of beneficial effects. Antonie Van Leeuwenhoek 82 (2002), 279–289.
154. Papadimitriou, K., Zoumpopoulou, G., Foligne, B., Alexandraki, V., Kazou, M., Pot, B., et al. Discovering probiotic microorganisms: In vitro, in vivo, genetic and omics approaches. Frontiers in Microbiology, 6, 2015 article no. 58.
155. Pascual, D.W., Suo, Z., Cao, L., Avci, R., Yang, X., Attenuating gene expression (AGE) for vaccine development. Virulence 4 (2013), 384–390.
156. Perez Chaia, A., Zarate, G., Oliver, G., The probiotic properties of propionibacteria. Lait 79 (1999), 175–185.
157. Petersson, L.G., Magnusson, K., Hakestam, U., Baigi, A., Twetman, S., Reversal of primary root caries lesions after daily intake of milk supplemented with fluoride and probiotic lactobacilli in older adults. Acta Odontologica Scandinavica 69 (2011), 321–327.
158. Petti, S., Tarsitani, G., Simonetti D'Arca, A., Antibacterial activity of yoghurt against viridans streptococci in vitro. Archives of Oral Biology 53 (2008), 985–990.
159. Picard, C., Fioramonti, J., Francois, A., Robinson, T., Neant, F., Matuchansky, C., Review article: Bifidobacteria as probiotic agents –physiological effects and clinical benefits. Alimentary Pharmacology and Therapeutics 22 (2005), 495–512.
160. Piwat, S., Sophatha, B., Teanpaisan, R., An assessment of adhesion, aggregation and surface charges of Lactobacillus strains derived from the human oral cavity. Letters in Applied Microbiology 61 (2015), 98–105.
161. Prat, J., Franceschi, S., Cancers of the female reproductive organs. Stewart, B.W., Wild, C.P., (eds.) World Cancer report 2014, 2014, International Agency for Research on Cancer, Lyon, France, 660–683.
162. Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
163. Rafter, J., Bennett, M., Caderni, G., Clune, Y., Hughes, R., Karlsson, P.C., et al. Dietary synbiotics reduce cancer risk factors in polypectomized and colon cancer patients. The American Journal of Clinical Nutrition 85 (2007), 488–496.
164. Reid, G., The growth potential for dairy probiotics. International Dairy Journal 49 (2015), 16–22.
165. Reigstad, C.S., Salmonson, C.E., Rainey, J.F. 3rd, Szurszewski, J.H., Linden, D.R., Sonnenburg, J.L., et al. Gut microbes promote colonic serotonin production through an effect of chain fatty acids on enterochromaffin cells. FASEB Journal 29 (2015), 1395–1403.
166. Reynolds, E.C., Dairy components in oral health. Australian Journal of Dairy Technology 58 (2003), 79–81.
167. Rezende, R.M., Oliveira, R.P., Medeiros, S.R., Gomes-Santos, A.C., Alves, A.C., Loli, F.G., et al. Hsp65-producing Lactococcus lactis prevents experimental autoimmune encephalomyelitis in mice by inducing CD4+LAP+ regulatory T cells. Journal of Autoimmunity 40 (2013), 45–57.
168. Rigaux, P., Daniel, C., Hisbergues, M., Muraille, E., Hols, P., Pot, B., et al. Immunomodulatory properties of Lactobacillus plantarum and its use as a recombinant vaccine against mite allergy. Allergy 64 (2009), 406–414.
169. Rousseaux, C., Thuru, X., Gelot, A., Barnich, N., Neut, C., Dubuquoy, L., et al. Lactobacillus acidophilus modulates intestinal pain and induces opioid and cannabinoid receptors. Nature Medicine 13 (2007), 35–37.
170. Ruan, Y., Sun, J., He, J., Chen, F., Chen, R., Chen, H., Effect of probiotics on glycemic control: A systematic review and meta-analysis of randomized, controlled trials. PLoS One, 10, 2015, e0132121.
171. Ruijschop, R.M.A.J., Boelrijk, A.E.M., te Giffel, M.C., Satiety effects of a dairy beverage fermented with propionic acid bacteria. International Dairy Journal 18 (2008), 945–950.
172. Russell, W.R., Gratz, S.W., Duncan, S.H., Holtrop, G., Ince, J., Scobbie, L., et al. protein, reduced-carbohydrate weight-loss diets promote metabolite profiles likely to be detrimental to colonic health. American Journal of Clinical Nutrition 93 (2011), 1062–1072.
173. Saade, F., Petrovsky, N., Technologies for enhanced efficacy of DNA vaccines. Expert Review of Vaccines 11 (2012), 189–209.
174. Saez, J.M., Possible usefulness of growth hormone/insulin-like growth factor-I axis in Alzheimer's disease treatment. Endocrine, Metabolic and Immune Disorders Drug Targets 12 (2012), 274–286.
175. Salminen, S., von Wright, A., Morelli, L., Marteau, P., Brassart, D., de Vos, W.M., et al. Demonstration of safety of probiotics –a review. International Journal of Food Microbiology 44 (1998), 93–106.
176. Saxelin, M., Probiotic formulations and applications, the current probiotics market, and changes in the marketplace: A European perspective. Clinical Infectious Diseases, 46, 2008 S76–79 and S144–151.
177. Schilderink, R., Verseijden, C., de Jonge, W.J., Dietary inhibitors of histone deacetylases in intestinal immunity and homeostasis. Frontiers in Immunology, 4, 2013 article no. 226.
178. Schwarzer, M., Repa, A., Daniel, C., Schabussova, I., Hrncir, T., Pot, B., et al. Neonatal colonization of mice with Lactobacillus plantarum producing the aeroallergen Bet v. 1 biases towards Th1 and T-regulatory responses upon systemic sensitization. Allergy 66 (2011), 368–375.
179. Sender, R., Fuchs, S., Milo, R., Revised estimates for the number of human and bacteria cells in the body. PLoS Biology, 14, 2016, e1002533.
180. Sharma, A., Rath, G.K., Chaudhary, S.P., Thakar, A., Mohanti, B.K., Bahadur, S., Lactobacillus brevis CD2 lozenges reduce radiation-and chemotherapy-induced mucositis in patients with head and neck cancer: A randomized double-blind placebo-controlled study. European Journal of Cancer 48 (2012), 875–881.
181. Singh, R.P., Damle, S.G., Chawla, A., Salivary mutans streptococci and lactobacilli modulations in young children on consumption of probiotic ice-cream containing Bifidobacterium lactis Bb12 and Lactobacillus acidophilus La5. Acta odontologica Scandinavica 69 (2011), 389–394.
182. Slawik, S., Staufenbiel, I., Schilke, R., Nicksch, S., Weinspach, K., Stiesch, M., et al. Probiotics affect the clinical inflammatory parameters of experimental gingivitis in humans. European Journal of Clinical Nutrition 65 (2011), 857–863.
183. Staab, B., Eick, S., Knofler, G., Jentsch, H., The influence of a probiotic milk drink on the development of gingivitis: A pilot study. Journal of Clinical Periodontology 36 (2009), 850–856.
184. Stamatova, I., Kari, K., Vladimirov, S., Meurman, J.H., In vitro evaluation of yoghurt starter lactobacilli and Lactobacillus rhamnosus GG adhesion to saliva-coated surfaces. Oral Microbiology and Immunology 24 (2009), 218–223.
185. Stecksen-Blicks, C., Sjostrom, I., Twetman, S., Effect of long-term consumption of milk supplemented with probiotic lactobacilli and fluoride on dental caries and general health in preschool children: A cluster-randomized study. Caries Research 43 (2009), 374–381.
186. Steenbergen, L., Sellaro, R., van Hemert, S., Bosch, J.A., Colzato, L.S., A randomized controlled trial to test the effect of multispecies probiotics on cognitive reactivity to sad mood. Brain, Behavior, and Immunity 48 (2015), 258–264.
187. Steidler, L., Neirynck, S., Huyghebaert, N., Snoeck, V., Vermeire, A., Goddeeris, B., et al. Biological containment of genetically modified Lactococcus lactis for intestinal delivery of human interleukin 10. Nature Biotechnology 21 (2003), 785–789.
188. St-Onge, M.P., Farnworth, E.R., Jones, P.J., Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. American Journal of Clinical Nutrition 71 (2000), 674–681.
189. Sudo, N., Chida, Y., Aiba, Y., Sonoda, J., Oyama, N., Yu, X.N., et al. Postnatal microbial colonization programs the hypothalamic-pituitary-adrenal system for stress response in mice. Journal of Physiology 558 (2004), 263–275.
190. Sun, J., Buys, N.J., Glucose-and glycaemic factor-lowering effects of probiotics on diabetes: A meta-analysis of randomised placebo-controlled trials. British Journal of Nutrition 115 (2016), 1167–1177.
191. Takei, S., Omoto, C., Kitagawa, K., Morishita, N., Katayama, T., Shigemura, K., et al. Oral administration of genetically modified Bifidobacterium displaying HCV-NS3 multi-epitope fusion protein could induce an HCV-NS3-specific systemic immune response in mice. Vaccine 32 (2014), 3066–3074.
192. Thangaraju, M., Cresci, G.A., Liu, K., Ananth, S., Gnanaprakasam, J.P., Browning, D.D., et al. GPR109A is a G-protein-coupled receptor for the bacterial fermentation product butyrate and functions as a tumor suppressor in colon. Cancer Research 69 (2009), 2826–2832.
193. Thomas, C., Pellicciari, R., Pruzanski, M., Auwerx, J., Schoonjans, K., Targeting bile-acid signalling for metabolic diseases. Nature Reviews. Drug Discovery 7 (2008), 678–693.
194. Tilg, H., Moschen, A.R., Kaser, A., Obesity and the microbiota. Gastroenterology 136 (2009), 1476–1483.
195. Toi, M., Hirota, S., Tomotaki, A., Sato, N., Hozumi, Y., Anan, K., et al. Probiotic beverage with soy isoflavone consumption for breast cancer prevention: A case-control study. Current Nutrition and Food Science 9 (2013), 194–200.
196. Tonucci, L.B., Olbrich Dos Santos, K.M., Licursi de Oliveira, L., Rocha Ribeiro, S.M., Duarte Martino, H.S., Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clinical Nutrition, 2015 in press.
197. Twetman, S., Are we ready for caries prevention through bacteriotherapy?. Brazilian Oral Research 26 (2012), 64–70.
198. Upadrasta, A., Madempudi, R.S., Probiotics and blood pressure: Current insights. Integrated Blood Pressure Control 9 (2016), 33–42.
199. Vandenplas, Y., Huys, G., Daube, G., Probiotics: An update. Jornal de Pediatria 91 (2015), 6–21.
200. Van't Veer, P., Dekker, J.M., Lamers, J.W., Kok, F.J., Schouten, E.G., Brants, H.A., et al. Consumption of fermented milk products and breast cancer: A case-control study in The Netherlands. Cancer Research 49 (1989), 4020–4023.
201. Veloso, T.R., Mancini, S., Giddey, M., Vouillamoz, J., Que, Y.A., Moreillon, P., et al. Vaccination against Staphylococcus aureus experimental endocarditis using recombinant Lactococcus lactis expressing ClfA or FnbpA. Vaccine 33 (2015), 3512–3517.
202. Verhoeven, V., Renard, N., Makar, A., Van Royen, P., Bogers, J.P., Lardon, F., et al. Probiotics enhance the clearance of human papillomavirus-related cervical lesions: A prospective controlled pilot study. European Journal of Cancer Prevention 22 (2013), 46–51.
203. Vorobjeva, L.I., Iljasova, O.V., Khodjaev, E.Y., Ponomareva, G.M., Varioukhina, S.Y., Inhibition of induced mutagenesis in Salmonella typhimurium by the protein of Propionibacterium freudenreichii subsp. shermanii. Anaerobe 7 (2001), 37–44.
204. Vorobjeva, L.I., Khodjaev, E.Y.U., Vorobjeva, N.V., Propionic acid bacteria as probiotics. Microbial Ecology in Health and Disease 20 (2008), 109–112.
205. de Vuyst, L., Vincent, P., Makras, E., Leroy, F., Pot, B., Peptide extracts from cultures of certain Lactobacilli Inhibit Helicobacter pylori. Probiotics and Antimicrobial Proteins 2 (2010), 26–36.
206. Wang, L., Christophersen, C.T., Sorich, M.J., Gerber, J.P., Angley, M.T., Conlon, M.A., Elevated fecal short chain fatty acid and ammonia concentrations in children with autism spectrum disorder. Digestive Diseases and Sciences 57 (2012), 2096–2102.
207. Wang, M., Gao, Z., Zhang, Y., Pan, L., Lactic acid bacteria as mucosal delivery vehicles: A realistic therapeutic option. Applied Microbiology and Biotechnology 100 (2016), 5691–5701.
208. Wells, J.M., Wilson, P.W., Norton, P.M., Gasson, M.J., Le Page, R.W., Lactococcus lactis: High-level expression of tetanus toxin fragment C and protection against lethal challenge. Molecular Microbiology 8 (1993), 1155–1162.
209. Wikoff, W.R., Anfora, A.T., Liu, J., Schultz, P.G., Lesley, S.A., Peters, E.C., et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proceedings of the National Academy of Sciences 106 (2009), 3698–3703.
210. Williams, J.H., Phillips, T.D., Jolly, P.E., Stiles, J.K., Jolly, C.M., Aggarwal, D., Human aflatoxicosis in developing countries: A review of toxicology, exposure, potential health consequences, and interventions. American Journal of Clinical Nutrition 80 (2004), 1106–1122.
211. Windey, K., De Preter, V., Verbeke, K., Relevance of protein fermentation to gut health. Molecular Nutrition and Food Research 56 (2012), 184–196.
212. Worthley, D.L., Le Leu, R.K., Whitehall, V.L., Conlon, M., Christophersen, C., Belobrajdic, D., et al. A human, double-blind, placebo-controlled, crossover trial of prebiotic, probiotic, and synbiotic supplementation: Effects on luminal, inflammatory, epigenetic, and epithelial biomarkers of colorectal cancer. American Journal of Clinical Nutrition 90 (2009), 578–586.
213. Yadav, H., Lee, J.H., Lloyd, J., Walter, P., Rane, S.G., Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. Journal of Biological Chemistry 288 (2013), 25088–25097.
214. Yanine, N., Araya, I., Brignardello-Petersen, R., Carrasco-Labra, A., González, A., Preciado, A., et al. Effects of probiotics in periodontal diseases: A systematic review. Clinical Oral Investigations 17 (2013), 1627–1634.
215. Yano, J.M., Yu, K., Donaldson, G.P., Shastri, G.G., Ann, P., Ma, L., et al. Indigenous bacteria from the gut microbiota regulate host serotonin biosynthesis. Cell 161 (2015), 264–276.
216. Yin, Y.N., Yu, Q.F., Fu, N., Liu, X.W., Lu, F.G., Effects of four bifidobacteria on obesity in high-fat diet induced rats. World Journal of Gastroenterology 16 (2010), 3394–3401.
217. Yu, Z., Huang, Z., Sao, C., Huang, Y., Zhang, F., Ma, G., et al. Oral immunization of mice using Bifidobacterium longum expressing VP1 protein from enterovirus 71. Archives of Virology 158 (2013), 1071–1077.
218. Yu, A.Q., Li, L., The potential role of probiotics in cancer prevention and treatment. Nutrition and Cancer 68 (2016), 535–544.
219. Zarrati, M., Salehi, E., Nourijelyani, K., Mofid, V., Zadeh, M.J., Najafi, F., et al. Effects of probiotic yogurt on fat distribution and gene expression of proinflammatory factors in peripheral blood mononuclear cells in overweight and obese people with or without loss diet. Journal of the American College of Nutrition 33 (2014), 417–425.
220. Zhou, L., Foster, J.A., Psychobiotics and the gut-brain axis: In the pursuit of happiness. Neuropsychiatric Disease and Treatment 11 (2015), 715–723.
221. Zhu, Y., Xiao, L., Shen, D., Hao, Y., Competition between yogurt probiotics and periodontal pathogens in vitro. Acta Odontologica Scandinavica 68 (2010), 261–268.